These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39158627)

  • 1. GDNF's Role in Mitigating Intestinal Reactive Gliosis and Inflammation to Improve Constipation and Depressive Behavior in Rats with Parkinson's disease.
    Xiaoling Q; Yurong G; Ke X; Yuxiang Q; Panpan A; Yinzhen D; Xue L; Tingting L; Chuanxi T
    J Mol Neurosci; 2024 Aug; 74(3):78. PubMed ID: 39158627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroacupuncture improves gastrointestinal motility through a central-cholinergic pathway-mediated GDNF releasing from intestinal glial cells to protect intestinal neurons in Parkinson's disease rats.
    Zhang C; Chen T; Fan M; Tian J; Zhang S; Zhao Z; Liu X; Ma H; Yang L; Chen Y
    Neurotherapeutics; 2024 Jul; 21(4):e00369. PubMed ID: 38744625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.
    Smith MP; Cass WA
    Neurosci Lett; 2007 Feb; 412(3):259-63. PubMed ID: 17125923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
    Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
    Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial-derived neurotrophic factor reduces inflammation and improves delayed colonic transit in rat models of dextran sulfate sodium-induced colitis.
    Liu GX; Yang YX; Yan J; Zhang T; Zou YP; Huang XL; Gan HT
    Int Immunopharmacol; 2014 Mar; 19(1):145-52. PubMed ID: 24462388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of electroacupuncture on gastrointestinal motility in rats with slow transit constipation based on GDNF methylation modification].
    Cao Y; Zhong F; Wen Q; Fang C; Xia YW; Luo R; Kuang HJ; Zhang W
    Zhen Ci Yan Jiu; 2022 Feb; 47(2):141-7. PubMed ID: 35218624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Fornai M; Colucci R; Tirotta E; Blandini F; Levandis G; Cerri S; Segnani C; Ippolito C; Bernardini N; Cseri K; Blandizzi C; Haskó G; Antonioli L
    J Neuroinflammation; 2016 Jun; 13(1):146. PubMed ID: 27295950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.
    Zhang X; Li Y; Liu C; Fan R; Wang P; Zheng L; Hong F; Feng X; Zhang Y; Li L; Zhu J
    Transl Res; 2015 Aug; 166(2):152-62. PubMed ID: 25766133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Ippolito C; Segnani C; Dolfi A; Errede M; Virgintino D; Fornai M; Antonioli L; Garelli F; Nericcio A; Colucci R; Cerri S; Blandini F; Blandizzi C; Bernardini N
    Neurobiol Dis; 2020 Jun; 139():104821. PubMed ID: 32088380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric glial cell reactivity in colonic layers and mucosal modulation in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
    Thomasi BBM; Valdetaro L; Ricciardi MCG; Hayashide L; Fernandes ACMN; Mussauer A; da Silva ML; da Cunha Faria-Melibeu A; Ribeiro MGL; de Mattos Coelho-Aguiar J; Campello-Costa P; Moura-Neto V; Tavares-Gomes AL
    Brain Res Bull; 2022 Sep; 187():111-121. PubMed ID: 35772606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.
    Yue P; Gao L; Wang X; Ding X; Teng J
    Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression of glial cell line-derived neutrophil factor and its effect on colonic transit function in slow transit constipation rats].
    Li YL; Lü B; Fan YH
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):752-5. PubMed ID: 20079213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons.
    Bu J; Qiao X; He Y; Liu J
    Life Sci; 2019 Aug; 231():116581. PubMed ID: 31220524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Intensity Pulsed Ultrasound Enhances Neurotrophic Factors and Alleviates Neuroinflammation in a Rat Model of Parkinson's Disease.
    Sung CY; Chiang PK; Tsai CW; Yang FY
    Cereb Cortex; 2021 Nov; 32(1):176-185. PubMed ID: 34196669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.
    Gavin AM; Walsh S; Wyatt S; O'Keeffe GW; Sullivan AM
    Neurosci Lett; 2014 Feb; 561():176-81. PubMed ID: 24373993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.